NVOH — Novo Nordisk A/S (B Shares) ADRhedged

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (t...

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.

Industry

ETF

Exchange

AMEX

First trade date

2025-01-07

The interactive platform loads with JavaScript. Research tools are for informational purposes.